[1] Z L LI, H WU, J Q ZHU et al. Novel strategy for optimized nanocatalytic tumor therapy: from an updated view. Small Science, 2200024(2022).
[2] B W YANG, Y CHEN, J L SHI. Nanocatalytic medicine. Advanced Materials(2019).
[3] A WU, M ZHU, Y ZHU. Copper-incorporated calcium silicate nanorods composite hydrogels for tumor therapy and skin wound healing. Journal of Inorganic Materials, 1203(2022).
[4] L P ZHU, Y L DAI, L Z GAO et al. Tumor microenvironment- modulated nanozymes for NIR-II-triggered hyperthermia-enhanced photo-nanocatalytic therapy via disrupting ROS homeostasis. International Journal of Nanomedicine, 16: 4559(2021).
[5] Z M TANG, P R ZHAO, H WANG et al. Biomedicine meets Fenton chemistry. Chemical Reviews, 1981(2021).
[6] Y L BIAN, B LIU, S LIANG et al. Cu-based MOFs decorated dendritic mesoporous silica as tumor microenvironment responsive nanoreactor for enhanced tumor multimodal therapy. Chemical Engineering Journal, 135046(2022).
[7] W J ZHANG, X Y ZHAO, J W LÜ et al. Progresses on hollow periodic mesoporous organosilicas: preparation and application in tumor therapy. Journal of Inorganic Materials, 1192(2022).
[8] Y LIU, Y H WANG, S Y SONG et al. Cancer therapeutic strategies based on metal ions. Chemical Science, 12234(2021).
[9] Q Q SUN, Z WANG, B LIU et al. Recent advances on endogenous/exogenous stimuli-triggered nanoplatforms for enhanced chemodynamic therapy. Coordination Chemistry Reviews, 451: 214267(2022).
[10] Z WANG, B LIU, Q Q SUN et al. Fusiform-like copper(II) based metal-organic framework through relief hypoxia and GSH-depletion co-enhanced starvation and chemodynamic synergetic cancer therapy. ACS Applied Materials & Interfaces, 17254(2020).
[11] N SHENOY, E CREAGAN, T WITZIG et al. Ascorbic acid in cancer treatment: let the phoenix fly.. Cancer Cell, 700(2018).
[12] C M DOSKEY, V BURANASUDJA, B A WAGNER et al. Tumor cells have decreased ability to metabolize H2O2: implications for pharmacological ascorbate in cancer therapy. Redox Biology, 10: 274(2016).
[13] B W YANG, J L SHI. Ascorbate tumor chemotherapy by an iron- engineered nanomedicine catalyzed tumor-specific pro-oxidation. Journal of the American Chemical Society, 21775(2020).
[14] Y J AI, H SUN, Z X GAO et al. Dual enzyme mimics based on metal-ligand cross-linking strategy for accelerating ascorbate oxidation and enhancing tumor therapy. Advanced Functional Materials, 2103581(2021).
[15] M Q WU, Y M DING, L L LI. Recent progress in the augmentation of reactive species with nanoplatforms for cancer therapy. Nanoscale, 11: 19658(2019).
[16] C FANG, Z DENG, G CAO et al. Co-ferrocene MOF/glucose oxidase as cascade nanozyme for effective tumor therapy. Advanced Functional Materials, 30: 1910058(2020).
[17] C Y ZHANG, L YAN, X WANG et al. Tumor microenvironment-responsive Cu2(OH)PO4 nanocrystals for selective and controllable radiosentization via the X-ray-triggered Fenton-like reaction. Nano Letters, 1749(2019).
[18] S M DONG, Y S DONG, T JIA et al. GSH depleted nanozymes with hyperthermia-enhanced dual enzyme-mimic activities for tumor nanocatalytic therapy. Advanced Materials(2020).
[19] T CHEN, W W ZENG, Y Q LIU et al. Cu-doped polypyrrole with multi-catalytic activities for sono-enhanced nanocatalytic tumor therapy. Small, 2270152(2022).
[20] J X NIU, S SUN, P F LIU et al. Copper-based nanozymes: properties and applications in biomedicine. Journal of Inorganic Materials, 489(2023).
[21] W J XU, Y P WANG, G H HOU et al. Tumor microenvironment responsive hollow nanoplatform for triple amplification of oxidative stress to enhance cuproptosis-based synergistic cancer therapy. Advanced Healthcare Materials(2023).
[22] W J XU, J M QIAN, G H HOU et al. A hollow amorphous bimetal organic framework for synergistic cuproptosis/ferroptosis/apoptosis anticancer therapy via disrupting intracellular redox homeostasis and copper/iron metabolisms. Advanced Functional Materials, 2205013(2022).
[23] L J SHAO, T S HU, X Y FAN et al. Intelligent nanoplatform with multitherapeutic modalities for synergistic cancer therapy. ACS Applied Materials & Interfaces, 13122(2022).
[24] Y L MIAO, Y D QIU, W J YANG et al. Charge reversible and bio-degradable nanocarriers showing dual pH-/reduction-sensitive disinte-gration for rapid site-specific drug delivery. Colloids and Surfaces B: Biointerfaces, 169: 313(2018).
[25] U TESTA, E PELOSI, G CASTELLI. New promising developments for potential therapeutic applications of high-dose ascorbate as an anticancer drug. Hematology/Oncology and Stem Cell Therapy, 179(2021).
[26] M LEVINE, P C VIOLET. Data Triumph at C.. Cancer cell, 467(2017).
[27] Y W WANG, J J CHEN, Z F TIAN et al. Potassium ferrate-loaded porphyrin-based (VI) metal-organic frameworks for combined photodymanic and chemodynamic tumor therapy. Journal of Inorganic Materials, 1305(2021).
[28] W C WU, L D YU, Q Z JIANG et al. Enhanced tumor-specific disulfiram chemotherapy by in situ Cu2+ chelation-initiated nontoxicity-to-toxicity transition. Journal of The American Chemical Society, 11531(2019).
[29] L C CHENG, H MA, M K SHAO et al. Synthesis of folate-chitosan nanoparticles loaded with ligustrazine to target folate receptor positive cancer cells. Molecular Medicine Reports, 1101(2017).
[30] J Y HONG, Z H SUN, Y J LI et al. Folate-modified annonaceous acetogenins nanosuspensions and their improved antitumor efficacy. International Journal of Nanomedicine, 5053(2017).
[31] L Z ZHANG, A J YANG, C P RUAN et al. Copper-nitrogen- coordinated carbon dots: transformable phototheranostics from precise PTT/PDT to post-treatment imaging-guided PDT for residual tumor cells. ACS Applied Materials & Interfaces, 325(2023).
